(Q38863290)

7 September 2017

title

Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study (English)

1 reference

7 September 2017

1 reference

8

1 reference

7 September 2017

Jack R W Brownrigg

1

1 reference

7 September 2017

Cian O Hughes

2

1 reference

7 September 2017

David Burleigh

3

1 reference

7 September 2017

Alan Karthikesalingam

4

1 reference

7 September 2017

Benjamin O Patterson

5

1 reference

7 September 2017

Peter J Holt

6

1 reference

7 September 2017

Matthew M Thompson

7

1 reference

7 September 2017

Kausik K Ray

9

1 reference

7 September 2017

Robert J Hinchliffe

10

1 reference

7 September 2017

publication date

20 May 2016

1 reference

The Lancet: Diabetes & Endocrinology

7 September 2017

published in

1 reference

7 September 2017

volume

4

1 reference

7 September 2017

issue

7

1 reference

7 September 2017

page(s)

588-597

1 reference

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Diabetes mellitus, fasting glucose, and risk of cause-specific death

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

The UK General Practice Research Database

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Linking physicians' pay to the quality of care--a major experiment in the United kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected data.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Creating medical and drug code lists to identify cases in primary care databases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Excess Mortality among Persons with Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Changes in diabetes-related complications in the United States, 1990-2010

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Effect of a multifactorial intervention on mortality in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Patterns and predictors of statin prescription in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Diabetic cardiovascular autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

Metabolic impairment in heart failure: the myocardial and systemic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2816%2930057-2

7 January 2021

10.1016/S2213-8587(16)30057-2

Identifiers

DOI

1 reference

7 September 2017

1 reference